Richard D. Francis, President and CEO at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 442,935 shares at $32.36 ($14.3M) on 2026-03-03, disclosed to the SEC on 2026-03-05.
Open-market sale of $14.3M TEVA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.36 | 30,903 | $1.0M | 7.0% |
| 2 | $32.36 | 412,032 | $13.3M | 93.0% |
| Total | $32.36 avg | 442,935 | $14.3M | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $1.5M | — | Filing → |
| TEVA | SELL | 2026-02-18 | $30.6M | — | Filing → |
| TEVA | SELL | 2025-03-06 | $751K | — | Filing → |